Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Scholz

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Hamostaseologie|February 23, 2022
GTH 2022: Sustainable CollaborationJan Beyer-Westendorf, Ute Scholz
Thrombosis and Haemostasis|November 5, 2003
Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasmaThomas Siegemund, Sirak Petros, Annelie Siegemund, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 17, 2016
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancyChristian Pfrepper, Annelie Siegemund, Sven Hildebrandt, et al.
Hamostaseologie|February 1, 2022
An Update on Laboratory Diagnostics in Haemophilia A and BJens Müller, Wolfgang Miesbach, Florian Prüller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2004
The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XIAnnelie Siegemund, Sirak Petros, Thomas Siegemund, et al.
Hamostaseologie|June 27, 2020
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Christina Hart, Rupert Bauersachs, Ute Scholz, et al.
Hamostaseologie|October 15, 2025
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI ActivityBehnaz Pezeshkpoor, Atanas Banchev, Barbara Preisler, et al.
Hamostaseologie|October 9, 2025
Laboratory Monitoring in Patients Receiving EmicizumabJens Müller, Martin Büchsel, Olga Oleshko, et al.
Hamostaseologie|October 15, 2025
Overview on Rare Congenital Bleeding Disorders and Epidemiological Data from the German Haemophilia Registry (DHR) and a Survey in Germany, Austria, and SwitzerlandKatharina Holstein, Kai Gutensohn, Rosa Sonja Alesci, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2020
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panelCarmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Hamostaseologie|February 23, 2022
GTH 2022: Sustainable CollaborationJan Beyer-Westendorf, Ute Scholz
Thrombosis and Haemostasis|November 5, 2003
Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasmaThomas Siegemund, Sirak Petros, Annelie Siegemund, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 17, 2016
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancyChristian Pfrepper, Annelie Siegemund, Sven Hildebrandt, et al.
Hamostaseologie|February 1, 2022
An Update on Laboratory Diagnostics in Haemophilia A and BJens Müller, Wolfgang Miesbach, Florian Prüller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2004
The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XIAnnelie Siegemund, Sirak Petros, Thomas Siegemund, et al.
Hamostaseologie|June 27, 2020
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Christina Hart, Rupert Bauersachs, Ute Scholz, et al.
Hamostaseologie|October 15, 2025
Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI ActivityBehnaz Pezeshkpoor, Atanas Banchev, Barbara Preisler, et al.
Hamostaseologie|October 9, 2025
Laboratory Monitoring in Patients Receiving EmicizumabJens Müller, Martin Büchsel, Olga Oleshko, et al.
Hamostaseologie|October 15, 2025
Overview on Rare Congenital Bleeding Disorders and Epidemiological Data from the German Haemophilia Registry (DHR) and a Survey in Germany, Austria, and SwitzerlandKatharina Holstein, Kai Gutensohn, Rosa Sonja Alesci, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2020
Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panelCarmen Escuriola-Ettingshausen, Günter Auerswald, Christoph Königs, et al.
Pageof 4